7.3.1 Combined hormonal contraceptives (CHC)

See Contraception Guidance for advice on

  • Missed pill
  • Risk factors
  • Counselling advice
  • Drug interactions
  • Practical advice
  • Emergency contraception

In the absence of any other clinical reason, the product of lower acquisition cost should be chosen

Monophasic low strength (21 day)

Loestrin 20®
  • Tablets ethinylestradiol 20 micrograms/ norethisterone 1mg (£0.90)
Gedarel® 20/150
  • Tablets ethinylestradiol 20 micrograms/ desogestrel 150 micrograms (£1.69)
Millinette® 20/75
  • Tablets ethinylestradiol 20 micrograms/ gestodene 75 micrograms (£1.80)
Mercilon®
  • Tablets ethinylestradiol 20 micrograms/ desogestrel 150 micrograms (£2.81)
Femodette®
  • Tablets ethinylestradiol 20 micrograms/ gestodene 75 micrograms (£2.95)

Monophasic standard strength (21 day)

Rigevidon®
  • Tablets ethinylestradiol 30 micrograms/ levonorgestrel 150 micrograms (£0.63)
Millinette® 30/75
  • Tablets ethinylestradiol 30 micrograms/ gestodene 75 micrograms (£1.37)
Gedarel® 30/150
  • Tablets ethinylestradiol 30 micrograms/ desogestrel 150 micrograms (£1.40)
Cilique® 250/35
  • Tablets ethinylestradiol 35 micrograms / norgestimate 250 micrograms (£1.55)
Lizinna®
  • Tablets ethinylestradiol 35 micrograms/ norgestimate 250 micrograms (£1.55)
Microgynon 30®
  • Tablets ethinylestradiol 30 micrograms/ levonorgestrel 150 micrograms (£0.94)
Femodene®
  • Tablets ethinylestradiol 30 micrograms/ gestodene 75 micrograms (£2.24)
Marvelon®
  • Tablets ethinylestradiol 30 micrograms/ desogestrel 150 micrograms (£2.37)
Lucette®
  • Tablets ethinylestradiol 30 micrograms/ drospirenone 3mg (£3.12)
Yasmin®
  • Tablets ethinylestradiol 30 micrograms/ drospirenone 3mg (£4.90)

Notes

  1. The risk of VTE in association with drospirenone-containing pills is higher than that for levonorgestrel-containing 'second generation' pills and may be similar to the risk for 'third-generation' pills that contain desogestrel or gestodene

Monophasic standard strength (28 days)

Microgynon 30 ED®
  • ED Tablets ethinylestradiol 30 micrograms/ levonorgestrel 150 micrograms (£1.00)

Phasic standard strength (28 days)

Logynon®
  • Tablets (£1.27)

Notes

  1. Phasic preparations should only be used where breakthrough bleeding is a problem. Headaches may be a problem with these preparations.

Vaginal (low strength)

NuvaRing®
  • Vaginal ring ethinylestradiol 15 micrograms and etonogestrel 120 micrograms / 24 hours (£29.70 = 3)

Notes

  1. Only to be prescribed to women wanting combined hormonal contraception who decline Long-Acting Reversible Contraceptive (LARC) and who fulfil at least one of the criteria listed below:
    1. those established on the method and wish to continue using it
    2. those with gastrointestinal problems (malabsorption, bowel disease, eating disorders causing vomiting) who are intolerant of transdermal CHC
    3. lactose intolerance and intolerant of transdermal CHC
    4. nausea with oral and transdermal CHC
    5. skin irritation or allergy to transdermal CHC and likely to have poor compliance with oral CHC
    6. compliance problems with oral and transdermal contraception
    7. cycle control problems on CHC

Transdermal (standard strength)

Evra®
  • Patches ethinylestradiol 20 micrograms/ norelgestronmin 150 micrograms / 24 hours (£6.50)

Notes

  1. For use in clients who meet any of the criteria below:
    1. Poor compliance with oral CHC or a past history of unplanned pregnancy due to poor pill compliance where another method is unsuitable or unacceptable.
    2. Those clients who choose to change from Depo-Provera® to this method after counselling about latest Depo-Provera® guidance, where other methods are unsuitable or unacceptable to the client.

 

Home > Formulary > Chapters > 7. Obstetrics, gynaecology, and urinary-tract disorders > 7.3 Contraceptives > 7.3.1 Combined hormonal contraceptives (CHC)

 

  • First line
  • Second line
  • Specialist
  • Hospital